CNN Anderson Cooper 360 June 4, 2024 02:44:00
Every two weeks, and it also targets those an loyd plaques in the brain. >> talk to us about the study that was done and how it worked. >> this was a global study in the new england journal of medicine, took place in about 250 sites around the world, 1,800 patients ages between 50-90 who had mild cognitive impairment or early alzheimer's dementia. they were followed for 18 months and they were given a scale to grade their clinical functioning, their mental functioning. that scale goes 0-18, 18 being the worst and 0 being the best. they all started around 0. the group that got the drug, their s...
Source: archive.org